Nektar Therapeutics Revenue, Growth & Competitor Profile

DBA NEKTAR

Company Profile & Annual Report for Nektar Therapeutics

Access the complete profile.

Nektar Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	5417 Scientific Research & Development Services
Address	455 Mission Bay Boulevard South San Francisco, CA 94158

Nektar Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Nektar Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Nektar Therapeutics is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Nektar Therapeutics is a publicly traded company on NMS using the ticker symbol NKTR. Detailed information on company financials and operating reports can be found here: NMS: NKTR

Nektar Therapeutics Annual Revenue and Growth Rate

Nektar Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Nektar Therapeutics's revenues are gauged from an analysis of company filings.

Investor Activity

Nektar Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
March 19, 2024	1	100%	$30 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Nektar Therapeutics is developing and marketing. Nektar Therapeutics doesn't have any recent trademark applications, indicating Nektar Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
KYVODA Analgesic preparations	05/24/2019
IMMUNIVATION Pharmaceuticals, namely, pharmaceutical preparations for the treatment and/or prophylaxis of diseases or medical conditions, namely, pharmaceutical preparations for the treatment of cancers; pharmaceuticals, namely, an anti-cancer agent	02/28/2019
INHERIS Pharmaceuticals, namely, pharmaceutical preparations having enhanced drug performance and/or drug delivery performance for the treatment and/or prophylaxis of diseases or medical conditions such as pain, diabetes, infections, cancers, and inflammations, or of diseases or medical conditions that affect the peripheral nerves, the adrenergic and/or cholinergic receptors, the histamine receptors, the expression and/or regulation of growth factors, the skeletal and/or smooth muscle systems, the cardiovascular system, the endocrine and/or hormone systems, the blood circulatory system, the immunological system, the synoptic and neuroeffector junctional sites, the reproductive system, the skeletal system, the autocoid system, the alimentary and/or excretory systems, and/or the central nervous system	12/18/2018

See all trademarks and details in the Full Report.

Market Share of Nektar Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Nektar Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Nektar Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
AUDENTES THERAPEUTICS	San Francisco, CA	100
NEKTAR THERAPEUTICS	San Francisco, CA	19
RDMD	San Francisco, CA	16
JAGUAR HEALTH	San Francisco, CA	12
ONESKIN	San Francisco, CA	6
SUNWINK PBC	San Francisco, CA	5

Future Competition: Nektar Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Nektar Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)